Peptide Profile

Epitalon

Telomerase Activator

Research Only10 sourcesShop Epitalon

Overview

Composition

Synthetic tetrapeptide (four-amino-acid sequence: Alanine-Glutamate-Asparagine-Glycine, or Ala-Glu-Asp-Gly) derived from epithalamin, a natural pineal gland extract

Mechanism of Action

Activates telomerase enzyme in experimental systems, influences telomere biology and replicative-capacity endpoints, regulates melatonin synthesis, exhibits antioxidant properties, and modulates neuroendocrine function

Primary Effects

Studied for telomerase activity, cellular-lifespan endpoints in vitro, circadian and melatonin biology, antioxidant signaling, neuroprotection, and longevity-related outcomes in animal models

Discovery & Background

Developed in Russia in the 1980s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, derived from epithalamin (pineal peptide extract) as a synthetic analog for easier production and study

1980s-1990s: Initial development and characterization in Russian research. 2000s: Expanded studies on telomerase activation and longevity-related animal endpoints. 2010s-present: Broader international interest, though rigorous human RCTs remain limited

Not FDA-approved; remains investigational/research compound with regional history and off-label longevity-market interest

Research Overview

Evidence is primarily from Russian preclinical and small clinical studies examining telomerase activation, circadian biology, and aging-related endpoints

01
Telomere elongation: demonstrated in human cell cultures (somatic cells, immune cells)
02
Increased telomerase activity in vitro and in vivo
03
Extended lifespan in animal models (rodents, Drosophila) by 10-25% in some studies
04
Improved circadian rhythms and melatonin regulation (pineal function support)
05
Enhanced antioxidant enzyme activity (SOD, catalase, glutathione peroxidase)
06
Neuroprotection: reduced age-related cognitive decline and neurodegeneration markers in animal models
07
Cardiovascular benefits: improved endothelial function, reduced age-related vascular changes
08
Reduced cancer incidence in aged rodents (some studies)
09
Skin, hair, and vitality reports are largely anecdotal or uncontrolled
10
Small human trials, mostly Russian, report biomarker changes, though Western large-scale RCTs are lacking

No FDA approval; limited rigorous human data from Western RCTs. Evidence primarily from Russian research, animal models, and off-label use

Safety Considerations

Monitoring

Telomere length (specialized labs, optional but ideal)
Sleep quality and circadian rhythm markers
Cognitive function and vitality self-assessment
Antioxidant markers (if available)
Overall healthspan indicators (energy, recovery, immune function)

Side Effects

Generally Well-Tolerated

Published safety reporting is limited and largely region-specific
Drowsiness or improved sleep (melatonin modulation)
Rare reports of vivid dreams or altered sleep architecture (typically positive)
Minimal reported adverse effects in available regional and anecdotal reports, with limited standardized safety capture

Theoretical Concerns

Telomerase activation in cancer biology is a theoretical concern that requires caution, especially in people with active or prior malignancy
Long-term human safety data limited, particularly in Western populations

Contraindications

Active cancer or history of malignancy (theoretical telomerase/cancer concern—consult oncologist)
Hypersensitivity to epitalon or components
Pregnancy or breastfeeding (insufficient safety data)
Caution in conditions where cell proliferation is a concern

Educational Notice

Epitalon is an investigational telomerase- and circadian-biology peptide with evidence concentrated in Russian research, cell studies, and animal models. It lacks FDA approval and large independent RCTs for therapeutic or longevity claims. Telomerase biology creates theoretical cancer-related caution, and long-term safety in diverse populations remains uncertain. Compounded quality varies.

References